Journal rankings · indicator year 2001
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2001
Oncology journal rankings 2001
88 ranked journals · Subfield in Medicine
Oncology has 88 ranked journals in 2001. The median OJR rose 0.07 on 2000 to 0.62, below the world average of 1.00; Q1 starts at OJR 1.07. The top three are CA A Cancer Journal for Clinicians, Nature Medicine, and Journal of Clinical Oncology.
Ranks and citation indicators: 2001. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1998–2000, the window the 2001 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery336
- Pulmonary and Respiratory Medicine128
- Public Health, Environmental and Occupational Health118
- Cardiology and Cardiovascular Medicine111
- Oncology88
- Epidemiology81
- Infectious Diseases73
- Psychiatry and Mental health71
- Neurology63
- Physiology62
- Radiology, Nuclear Medicine and Imaging62
- Endocrinology, Diabetes and Metabolism51
Show all 42 subfields
- Dermatology46
- Orthopedics and Sports Medicine44
- Pediatrics, Perinatology and Child Health44
- Hematology43
- Ophthalmology43
- Obstetrics and Gynecology35
- Nephrology24
- Pharmacology24
- Rheumatology24
- Emergency Medicine23
- Reproductive Medicine20
- Otorhinolaryngology18
- Rehabilitation15
- Complementary and alternative medicine14
- Pathology and Forensic Medicine14
- Geriatrics and Gerontology13
- Critical Care and Intensive Care Medicine11
- Immunology and Allergy9
- Genetics8
- Anesthesiology and Pain Medicine7
- Hepatology7
- Urology5
- Gastroenterology4
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
88 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2000. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1998–2000, the window the 2001 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1998–2000 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2001. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 8.91Q1 | 24.16 6.54 up from 2000 | 75 | 100% | $4,330 | ||
2Nature MedicineNature Portfolio · United States | 5.68Q1 | 12.66 1.19 up from 2000 | 1,285 | 11% | $12,690 | ||
3Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 4.16Q1 | 8.48 0.20 up from 2000 | 1,653 | 2% | — | ||
4JNCI Journal of the National Cancer InstituteOxford University Press · United States | 4.00Q1 | 8.96 0.97 up from 2000 | 858 | 25% | $5,436 | ||
5Seminars in Cancer BiologyElsevier BV · United States | 2.43Q1 | 5.07 0.38 down from 2000 | 87 | 6% | $6,060 | ||
6Clinical Pharmacology & TherapeuticsWiley · United States | 2.26Q1 | 3.84 0.17 up from 2000 | 440 | 1% | $4,410 | ||
7JNCI MonographsOxford University Press · United Kingdom | 1.81Q1 | 2.24 0.41 up from 2000 | 94 | 74% | — | ||
8Psycho-OncologyWiley · United Kingdom | 1.59Q1 | 2.42 0.11 up from 2000 | 154 | 4% | $4,940 | ||
9Cancer Causes & ControlSpringer Science+Business Media · Netherlands | 1.58Q1 | 2.81 0.32 up from 2000 | 265 | 3% | $3,890 | ||
10CancerWiley · United States | 1.57Q1 | 3.08 0.15 up from 2000 | 2,831 | 48% | $4,790 | ||
11Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 1.51Q1 | 3.31 0.82 up from 2000 | 108 | 10% | $4,090 | ||
12British Journal of CancerSpringer Nature · United Kingdom | 1.45Q1 | 3.49 0.36 up from 2000 | 2,162 | 97% | $5,190 | ||
13Annals of OncologyElsevier BV · Netherlands | 1.34Q1 | 2.59 0.27 up from 2000 | 1,042 | 85% | $5,080 | ||
14Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.34Q1 | 2.22 0.35 down from 2000 | 224 | 3% | $3,950 | ||
15JBIC Journal of Biological Inorganic ChemistrySpringer Science+Business Media · Germany | 1.32Q1 | 2.54 0.07 up from 2000 | 234 | 8% | $3,990 | ||
16European Journal of CancerElsevier BV · United Kingdom | 1.31Q1 | 2.91 0.56 up from 2000 | 1,107 | 1% | $4,270 | ||
17Cancer Treatment ReviewsElsevier BV · United Kingdom | 1.25Q1 | 3.38 1.23 up from 2000 | 84 | 0% | $4,910 | ||
18Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 1.24Q1 | 2.91 0.78 up from 2000 | 284 | 0% | — | ||
19International Journal of Clinical Pharmacology and TherapeuticsDustri-Verlag · Germany | 1.20Q1 | 1.52 1.52 up from 2000 | 83 | 0% | — | ||
20International Journal of CancerWiley · United States | 1.20Q1 | 2.96 0.24 up from 2000 | 2,811 | 52% | $5,030 | ||
21Cancer NursingLippincott Williams & Wilkins · United States | 1.15Q1 | 1.19 0.01 up from 2000 | 181 | 1% | — | ||
22Supportive Care in CancerSpringer Science+Business Media · Germany | 1.07Q1 | 1.59no change | 184 | 2% | $4,690 | ||
23Investigational New DrugsSpringer Science+Business Media · Netherlands | 1.04Q2 | 3.32 1.98 up from 2000 | 124 | 2% | $4,690 | ||
24MicrocirculationWiley · United States | 1.00Q2 | 2.32 0.02 down from 2000 | 107 | 0% | $3,920 | ||
25Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 0.98Q2 | 2.26 0.85 up from 2000 | 174 | 4% | $4,190 | ||
26Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 0.94Q2 | 1.79 0.40 up from 2000 | 1,084 | 1% | — | ||
27Journal of Clinical PathologyBMJ · United Kingdom | 0.94Q2 | 1.75 0.10 down from 2000 | 697 | 98% | — | ||
28OncologyKarger Publishers · Switzerland | 0.93Q2 | 1.94 0.50 up from 2000 | 323 | 14% | — | ||
29The OncologistOAAlphaMed Press · United Kingdom | 0.92Q2 | 2.04 0.79 up from 2000 | 194 | 56% | $3,852 | ||
30Cancer Chemotherapy and PharmacologySpringer Science+Business Media · Germany | 0.84Q2 | 2.07 0.18 up from 2000 | 410 | 0% | $4,390 | ||
31Journal of Clinical Pharmacy and TherapeuticsWiley · United Kingdom | 0.80Q2 | 1.35 0.41 up from 2000 | 172 | 39% | $2,700 | ||
32Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 0.78Q2 | 2.10 0.04 down from 2000 | 240 | 100% | $4,590 | ||
33Journal of Surgical OncologyWiley · United States | 0.77Q2 | 1.28 0.15 down from 2000 | 441 | 6% | $4,570 | ||
34Journal of Cancer Research and Clinical OncologyOASpringer Science+Business Media · Germany | 0.77Q2 | 2.01 0.49 up from 2000 | 265 | 100% | $4,390 | ||
35International Journal of Colorectal DiseaseSpringer Science+Business Media · Germany | 0.77Q2 | 1.56no change | 137 | 3% | $3,790 | ||
36Cancer InvestigationTaylor & Francis · United Kingdom | 0.73Q2 | 1.45 0.17 up from 2000 | 277 | 1% | — | ||
37Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 0.72Q2 | 1.91 0.73 up from 2000 | 486 | 2% | — | ||
38Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 0.71Q2 | 1.23 0.32 up from 2000 | 646 | 0% | — | ||
39Journal of Inorganic BiochemistryElsevier BV · United States | 0.70Q2 | 1.49 0.37 up from 2000 | 478 | 5% | $4,220 | ||
40Journal of Medical ScreeningSAGE Publishing · United Kingdom | 0.69Q2 | 1.52 0.01 up from 2000 | 74 | 27% | $4,150 | ||
41Journal of Cutaneous PathologyWiley · United Kingdom | 0.67Q2 | 1.59 0.25 up from 2000 | 174 | 16% | $3,570 | ||
42Cancer Detection and PreventionElsevier BV · Netherlands | 0.65Q2 | 1.55 0.34 up from 2000 | 133 | — | — | ||
43Inorganica Chimica ActaElsevier BV · Netherlands | 0.64Q2 | 1.16 0.04 up from 2000 | 1,764 | 2% | $3,830 | ||
44European Journal of EpidemiologySpringer Science+Business Media · Italy | 0.62Q2 | 0.81 0.31 down from 2000 | 424 | 6% | $3,690 | ||
45Clinical & Experimental MetastasisSpringer Science+Business Media · Netherlands | 0.62Q3 | 1.48 0.24 down from 2000 | 267 | — | $5,090 | ||
46Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 0.62Q3 | 1.57 0.11 down from 2000 | 262 | 2% | — | ||
47Acta OncologicaOATaylor & Francis · United Kingdom | 0.61Q3 | 1.31 0.43 up from 2000 | 420 | 100% | — | ||
48American Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 0.59Q3 | 1.07 0.03 up from 2000 | 423 | 1% | — | ||
49Melanoma ResearchLippincott Williams & Wilkins · United Kingdom | 0.55Q3 | 1.51 0.32 up from 2000 | 250 | 2% | — | ||
50Tumor BiologyOASAGE Publishing · Switzerland | 0.55Q3 | 1.08 0.26 down from 2000 | 163 | 5% | $2,000 |
Subfields of Medicine, with Oncology highlighted.
- Surgery336
- Pulmonary and Respiratory Medicine128
- Public Health, Environmental and Occupational Health118
- Cardiology and Cardiovascular Medicine111
- Oncology88
- Epidemiology81
- Infectious Diseases73
- Psychiatry and Mental health71
- Neurology63
- Physiology62
- Radiology, Nuclear Medicine and Imaging62
- Endocrinology, Diabetes and Metabolism51
- Dermatology46
- Orthopedics and Sports Medicine44
- Pediatrics, Perinatology and Child Health44
- Hematology43
- Ophthalmology43
- Obstetrics and Gynecology35
- Nephrology24
- Pharmacology24
- Rheumatology24
- Emergency Medicine23
- Reproductive Medicine20
- Otorhinolaryngology18
- Rehabilitation15
- Complementary and alternative medicine14
- Pathology and Forensic Medicine14
- Geriatrics and Gerontology13
- Critical Care and Intensive Care Medicine11
- Immunology and Allergy9
- Genetics8
- Anesthesiology and Pain Medicine7
- Hepatology7
- Urology5
- Gastroenterology4
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2001. Corpus-wide, 67.0% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
32 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1998–2000, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2001. Publication window: 1998–2000. How these summaries are calculated
- Ranked journals
- 88
- Window papers (baseline)
- 41,430 Change unavailable from indicator year 1998
- Median OJR
- 0.62 Change unavailable from indicator year 1998
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1998–2000 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.